Inspectors are finished with Wyeth drugmaking plant (Asbury Park Press)
U.S. regulators have finished inspecting Madison-based Wyeth's manufacturing plant in Puerto Rico, where past questions about safety have delayed new drug approvals. Wyeth will respond by mid-April to any remaining quality-control concerns identified by the U.S. Food and Drug Administration, the company said today in a statement. European regulators also inspected the plant in the week of March ...

Dendreon Corporation: The Next Biotech Winner (SeekingAlpha via Yahoo! Finance)
Hillel Shakked submits: Many have noticed Friday's remarkable price movement in Dendreon Corporation and are wondering what the upside from here is. In the report below, I will run a back-of-an-envelope analysis for DNDN's current evaluation and will discuss its longer term potential.

Dendreon's Positive Panel Surprise (The Motley Fool)
Shares of Dendreon jump after a FDA advisory panel finds in favor of its lead drug.